Is it dishonest to give patients placebo?
False
Journal club
Is it dishonest to give patients placebo?
Discuss the latest medical articles
We are all committed to honesty, I hope, both to ourselves and our patients. And yet repeated studies of the placebo effect show that our honesty can deprive patients of large subjective benefits. Fo
0
Cat:OffDutyForum:JournalClub
Cat:OffDutyForum:JournalClubDiscussion:8abd0a25-c4e1-4dde-8035-9887a8521765
Forums » Off duty » Journal club » Is it dishonest to give patients placebo?
|
Is it dishonest to give patients placebo?
posted at 20/7/2011 1:36 PM BST
on bmj.com
|
Posts: 77
First: 21/7/2010 Last: 10/5/2012 |
We are all committed to honesty, I hope, both to ourselves and our patients. And yet repeated studies of the placebo effect show that our honesty can deprive patients of large subjective benefits. For example, we all know of patients with real or presumed asthma who consume enormous quantities of beta-adrenergic inhalers without any objective evidence of severe bronchoconstriction. A few of them probably die as a result. Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma is a NEJM study which should make all doctors squirm a bit. Aims In prospective experimental studies in patients with asthma, it is difficult to determine whether responses to placebo differ from the natural course of physiological changes that occur without any intervention. This study compared the effects of a bronchodilator, two placebo interventions, and no intervention on outcomes in patients with asthma.Methods In a double-blind, crossover pilot study, 46 patients with asthma were randomly assigned to active treatment with an albuterol inhaler, a placebo inhaler, sham acupuncture, or no intervention. Using a block design, one each of these four interventions was administered in random order during four sequential visits (3 to 7 days apart); this procedure was repeated in two more blocks of visits (for a total of 12 visits by each patient). At each visit, spirometry was performed repeatedly over a period of 2 hours. Maximum forced expiratory volume in 1 second (FEV1) was measured, and patients' self-reported improvement ratings were recorded. Results Among the 39 patients who completed the study, albuterol resulted in a 20% increase in FEV1, as compared with approximately 7% with each of the other three interventions (P<0.001). However, patients' reports of improvement after the intervention did not differ significantly for the albuterol inhaler (50% improvement), placebo inhaler (45%), or sham acupuncture (46%), but the subjective improvement with all three of these interventions was significantly greater than that with the no-intervention control (21%) (P<0.001). Conclusions Although albuterol, but not the two placebo interventions, improved FEV1 in these patients with asthma, albuterol provided no incremental benefit with respect to the self-reported outcomes. Placebo effects can be clinically meaningful and can rival the effects of active medication in patients with asthma. However, from a clinical-management and research-design perspective, patient self-reports can be unreliable. An assessment of untreated responses in asthma may be essential in evaluating patient-reported outcomes. We suspect that they would get equal symptomatic benefit using a harmless placebo inhaler, and this pilot study from Harvard goes some way to demonstrating that. I say “some way” because the study seems to have timed the interventions to suit the investigators, not the patients. They received inhaled albuterol, inhaled placebo, sham acupuncture or simple waiting in cross-over fashion for a total of 12 visits. Inhaled albuterol was the only intervention that improved FEV1 but sham acupuncture and placebo inhaler were as good at relieving symptoms. For thousands of years, doctors were safer using placebos than active treatments; and that probably applies in certain areas today. But to use placebos deliberately is to become a charlatan and to undermine the scientific basis of medical progress. Discuss. P.S. One of the authors of this study declares direct payments from 20 pharma companies and grants from 9: it would be nice to think he will be doing similar studies on all their products. |
|
Re: Is it dishonest to give patients placebo?
posted at 20/7/2011 7:27 PM BST
on bmj.com
|
|
Re: Is it dishonest to give patients placebo?
posted at 15/8/2011 5:23 PM BST
on bmj.com
|
|
*Moderator*
Posts: 869
First: 10/9/2009 Last: 10/12/2011 |
Here is an interesting editorial written by a child and adolescent psychiatry fellow and an associate professor of medicine suggesting clinicians and family members may also have emotional responses when patients receive placebo treatments |
|
Re: Is it dishonest to give patients placebo?
posted at 3/9/2011 8:07 PM BST
on bmj.com
|
|
Re: Is it dishonest to give patients placebo?
posted at 5/1/2012 9:55 AM GMT
on bmj.com
|
|
Re: Is it dishonest to give patients placebo?
posted at 5/1/2012 2:36 PM GMT
on bmj.com
|





